©2025 RXinsider | RXinsider Market Intelligence Group | 2025
12
Professional Development & Innovation
• Leadership development, feedback culture, and DEI (e.g., LGBTQIA+ inclusion)
sessions support pharmacist engagement beyond clinical responsibilities.
• Innovation-focused talks on artificial intelligence, digital workflow improvements,
and adapting to practice change highlight forward-looking skill development.
• Programs targeting new practitioners and residents reflect ASCP’s investment in
succession planning and preparing the next generation of consultant pharmacists.
Patient Safety & Quality
• Foundational concerns around falls, delirium, readmissions, and medication safety
were prominent, signaling an ongoing push for risk mitigation in frail populations.
• Drug regimen review, anticoagulation stewardship, and transitions of care were
featured as practical interventions to improve health outcomes.
• Safety themes are being integrated into broader care models, with pharmacists
positioned as central quality drivers in long-term care environments.
Policy, Payment & Regulation
• Reimbursement for senior care pharmacy services was a focal point, with sessions
spotlighting new payment models and billing innovations for clinical pharmacist
roles.
• Regulatory insights, including DEA updates and controlled substance oversight,
signal a growing emphasis on pharmacist compliance within evolving legal
frameworks.
• Policy updates post-election and SNP (Special Needs Plan) discussions to help
pharmacists stay engaged in Medicare strategy and healthcare reform.
Technology & Product Theaters
• Product Theaters emphasizing emerging treatments in Alzheimer’s, Parkinson’s,
COPD, seizures, and metabolic conditions tailored for the long-term care population.
• Sessions highlighting automation, digital workflows, and medication management
tools signal increased interest in scalable, tech-enabled pharmacy operations.
• These sessions serve as a convergence point for clinical education and commercial
innovation, offering attendees early access to therapies and tools shaping the future
of long-term care pharmacy.